Post Profile

Cancer immunotherapy: Dual action of targeted T cells

Immune cells engineered to attack tumours can also be used to deliver cancer-fighting proteins.T cells that have been engineered to recognize tumours have shown promise as treatments for certain blood cancers. Hans-Guido Wendel at the Memorial Sloan-Kettering Cancer Center in New York, Karin Tarte
read more


Related Posts

New era of lung cancer treatment heralded by immunotherapy data

Health : Medical News Today

A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.For decades, scientists and doctors thought i...

New Cancer Immunotherapy Approach Combines Tumor Fighting Power with Fewer Side Effects, Study Shows

Health : Newswise Medical News

Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Ins...

Dual antigen targeting may improve CAR T cell cancer therapy

Academics / General Science : Science Codex

Chimeric antigen receptor T cells (CAR T cells) are a promising immunotherapy approach to cancer treatment in which a patient's own immune cells attack tumors by targeting an identifying marker, or antigen, that is displayed at high...

The Value and Cost of Immunotherapy Cancer Treatments

Health : Huffington Post: Healthy Living

Your body's first-line defense against foreign invaders is your own immune system. When it sees an invader, it unleashes T cells to destroy it. Some forms of cancer can trick the immune system into seeing cancer cells as healthy cel...

Patients' Own Genetically Altered Immune Cells Show Promise in Fighting Blood Cancer

Health : Newswise Medical News

In recent years, immunotherapy has emerged as a promising treatment for certain cancers. Now this strategy, which uses patients' own immune cells, genetically engineered to target tumors, has shown significant success against multip...


Copyright © 2016 Regator, LLC